Richard Steinhart
Direttore Finanziario/CFO presso BIOXCEL THERAPEUTICS, INC.
Patrimonio netto: 12 487 $ in data 31/05/2024
Posizioni attive di Richard Steinhart
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 08/11/2013 | - |
| Independent Dir/Board Member | 08/11/2013 | - | |
| ATOSSA THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 03/03/2014 | - |
| Independent Dir/Board Member | 01/03/2014 | - | |
| BIOXCEL THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01/10/2017 | - |
| Direttore Finanziario/CFO | 01/10/2017 | - |
Storia della carriera di Richard Steinhart
Precedenti posizioni note di Richard Steinhart
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Remedy Pharmaceuticals, Inc.
 Remedy Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Remedy Pharmaceuticals, Inc. develops and commercializes pharmaceutical ingridients. It focuses on small molecule drugs for acute central nervous system disorders. The company was founded by David M. Geliebter and Sven M. Jacobson in 2004 and is headquartered in New York, NY. | Direttore Finanziario/CFO | 14/10/2015 | 01/04/2017 |
| STRATA SKIN SCIENCES, INC. | Direttore Finanziario/CFO | 24/04/2006 | 31/12/2013 |
| Segretario Aziendale | 24/04/2006 | 31/12/2013 | |
| Treasurer | 24/04/2006 | 31/12/2013 | |
| TG THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/07/2004 | 01/01/2012 |
| Independent Dir/Board Member | 27/06/2011 | 01/01/2012 | |
| Forest Street Capital, LLC | Corporate Officer/Principal | 01/05/1992 | 24/04/2006 |
| EMISPHERE TECHNOLOGIES, INC. | Direttore Finanziario/CFO | 01/05/1991 | 01/05/1992 |
CW Group, Inc.
 CW Group, Inc. Investment ManagersFinance CW Group Inc. (CW Group) is a venture capital firm founded in 1982. The firm is headquartered in New York. | Direttore Finanziario/CFO | 01/01/1991 | 02/01/1992 |
| ░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ | - | |
| ░░░░░░░░░ | ░░░░░░░░░░ | - | |
| ░░░ ░░░░░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - | - |
Formazione di Richard Steinhart
| Pace University | Masters Business Admin |
Statistiche
Distribuzione geografica
| Stati Uniti | 13 |
Posizioni
| Director of Finance/CFO | 6 |
| Director/Board Member | 3 |
| Independent Dir/Board Member | 3 |
Settori
| Health Technology | 8 |
| Finance | 2 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 5 |
|---|---|
| TG THERAPEUTICS, INC. | Health Technology |
| STRATA SKIN SCIENCES, INC. | Health Technology |
| ATOSSA THERAPEUTICS, INC. | Health Technology |
| ACTINIUM PHARMACEUTICALS, INC. | Health Technology |
| BIOXCEL THERAPEUTICS, INC. | Health Technology |
| Aziende private | 6 |
|---|---|
Emisphere Technologies, Inc.
 Emisphere Technologies, Inc. Pharmaceuticals: MajorHealth Technology Emisphere Technologies, Inc. is a commercial stage specialty pharmaceutical company, which engages in the development of new formulations of existing products and chemical entities, using Eligen Technology. Its product pipelines include eligen B12, eligen12.com, eligen B12 information, and purchase eligen B12. The company was founded in 1986 and is headquartered in Roseland, NJ. | Health Technology |
CW Group, Inc.
CW Group, Inc. Investment ManagersFinance CW Group Inc. (CW Group) is a venture capital firm founded in 1982. The firm is headquartered in New York. | Finance |
Remedy Pharmaceuticals, Inc.
Remedy Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Remedy Pharmaceuticals, Inc. develops and commercializes pharmaceutical ingridients. It focuses on small molecule drugs for acute central nervous system disorders. The company was founded by David M. Geliebter and Sven M. Jacobson in 2004 and is headquartered in New York, NY. | Health Technology |
| SAE Ventures | |
| MELA Sciences Inc. | |
| Forest Street Capital, LLC |
- Borsa valori
- Insiders
- Richard Steinhart
- Esperienza
